Cytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controls

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Sundin, Johanna ^a   Rangel, Ignacio ^a   Repsilber, Dirk ^a   Brummer, Robert Jan ^a  

^a Örebro University   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; AKKERMANSIA MUCINIPHILA; ANAEROBIC BACTERIUM; ARTICLE; BACTEROIDES OVATUS; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; EUBACTERIUM LIMOSUM; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE FLORA; IRRITABLE COLON; MALE; NONHUMAN; PATHOGENESIS; POST INFECTIOUS IRRITABLE BOWEL SYNDROME; RUMINOCOCCUS GNAVUS; SUBDOLIGRANULUM VARIABILE; ADOLESCENT; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED;

EID: 84947577311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134836     Document Type: Article

References (36)

1. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004; 18(4):641-61. doi: 10.1016/j.bpg.2004.04.002 PMID: 15324705
2. Jalanka-Tuovinen J, Salojarvi J, Salonen A, Immonen O, Garsed K, Kelly FM, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2014; 63(11):1737-45. doi: 10.1136/gutjnl-2013-305994 PMID: 24310267.
3. Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog. 2011;3(1:). doi: 10.1186/1757-4749-3-6
4. Sundin J, Rangel I, Fuentes S, Heikamp-de Jong I, Hultgren-Hörnquist E, de Vos WM, et al. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Alimentary Pharmacology and Therapeutics. 2014;Epub ahead of print. doi: 10.1111/apt.13055
5. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6):804-11. doi: 10.1136/gut.47. 6.804 PMID: 11076879
6. Sundin J, Rangel I, Kumawat AK, Hultgren-Hörnquist E, Brummer R-J. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious IBS patients. Scan J Gastro. 2014; 49(9):1068-75. doi: 10.3109/00365521.2014.926982
7. Cotton JA, Beatty JK, Buret AG. Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol. 2011; 41(9):925-33. doi: 10.1016/j.ijpara.2011.05.002 PMID: 21683702
8. Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, et al. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest. 2011; 121- (5):1946-55. doi: 10.1172/JCI44447 PMID: 21490392
9. Martínez C, González-Castro A, Vicario M, Santos J. Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome. Gut Liver. 2012; 6(3):305-15. doi: 10.5009/gnl.2012.6.3. 305 PMID: 22844557
10. Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004; 20(11-12):1317-22. doi: 10.1111/j.1365-2036.2004.02284.x PMID: 15606393
11. Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, et al. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012; 46:52-5. doi: 10.1097/MCG.0b013e318264e918
12. Degnan BA, Macfarlane S, Quigley ME, Macfarlane GT. Starch utilization by Bacteroides ovatus isolated from the human large intestine. Curr Microbiol. 1997; 34(5):290-6. doi: 10.1007/s002849900184 PMID: 9099629
13. Falk P, Hoskins LC, Larson G. Bacteria of the human intestinal microbiota produce glycosidases specific for lacto-series glycosphingolipids. J Biochem. 1990; 108(3):466-74. PMID: 2277039
14. Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract Res Clin Gastroenterol. 2013; 27(1):25-38. doi: 10.1016/j.bpg.2013.03.001 PMID: 23768550
15. Kanauchi O, Fukuda M, Matsumoto Y, Ishii S, Ozawa T, Shimizu M, et al. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol. 2006; 12(7):1071-7 PMID: 16534848
16. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009; 294(1):1-8. doi: 10.1111/j.1574-6968.2009.01514.x PMID: 19222573
17. Kumawat AK, Strid H, Elgbratt K, Tysk C, Bohr J, Hultgren Hörnquist E. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+) 8(+) mucosal T cells. J Crohns Colitis. 2013; 7(9):694-705. doi: 10.1016/j.crohns.2012.08.014 PMID: 22995775
18. Computing FfS. R Development Core Team. Vinenna, Austria. 2014; ISBN 3-900051-07-0 (URL: http://www.R-project.org).
19. Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012; 46(5):356-66. doi: 10.1097/MCG.0b013e318247157c PMID: 22499071
20. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009; 136(6):1979-88. doi: 10.1053/j.gastro.2009.02.074 PMID: 19457422
21. Kanauchi O, Mitsuyama K, Komiyama Y, Yagi M, Andoh A, Sata M. Preventive effects of enzymetreated rice fiber in a restraint stress-induced irritable bowel syndrome model. Int J Mol Med 2010; 25- (4):547-55. doi: 10.3892/ijmm-00000376 PMID: 20198303
22. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008; 27(2):104-19. doi: 10.1111/j.1365-2036. 2007.03562.x PMID: 17973645
23. Kindt S, Van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, Bossuyt X, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009; 21(4):389-98. doi: 10.1111/j.1365-2982.2008.01220.x PMID: 19126184
24. Ortiz-Lucas M, Saz-Peiró P, Sebastián-Domingo JJ. Irritable bowel syndrome immune hypothesis. Part one: the role of lymphocytes and mast cells. Rev Esp Enferm Dig. 2010; 102(11):637-47. 1130-0108/2010/102/11/637-647. PMID: 21142384
25. Hamilton MJ, Sinnamon MJ, Lyng GD, Glickman JN, Wang X, Xing W, et al. Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci U S A. 2011; 108(1):290-5. doi: 10.1073/pnas.1005758108 PMID: 21173247
26. Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014;9(3:). doi: 10.1371/journal.pone. 0093144
27. Rodríguez-Fandiño O, Hernández-Ruíz J, López-Vidal Y, Charúa L, Bandeh-Moghaddam H, Minzoni A, et al. Intestinal recruiting and activation profiles in peripheral blood mononuclear cells in response to pathogen-associated molecular patterns stimulation in patients with IBS. Neurogastroenterol Motil. 2013; 25(11):872-e699. doi: 10.1111/nmo.12204 PMID: 23937411
28. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol. 2011; 106(2):329-3. doi: 10.1038/ajg.2010.438 PMID: 21102570
29. Belmonte L, Beutheu-Youmba S, Bertiaux-Vandaële N, Antonietti M, Lecleire S, Zalar A, et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One. 2012; 7(8):e42777 PMID: 23028414
30. McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther. 2011; 33(9):1045-52. doi: 10.1111/j.1365-2036.2011.04624.x PMID: 21453321
31. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007; 56(2):203-9. PMID: 17005763
32. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006; 101- (6):1288-94. PMID: 16771951
33. Harrell L, Wang Y, Antonopoulos D, Young V, Lichtenstein L, Huang Y, et al. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS One. 2012; 7(2): e32545. doi: 10.1371/journal.pone.0032545 PMID: 22389708
34. Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol. 2013; 14(7):660-7. doi: 10.1038/ni.2611 PMID: 23778793
35. Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2014;Nov 25([Epub ahead of print]).
36. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005; 128(3):541-51. doi: 10.1053/j.gastro.2004.11.050 PMID: 15765388